IVRO (Invitro International) Net Margin %: 8.70% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Invitro International Net Margin %?

Invitro International IVRO +1.33% Net Margin % is 8.70% as of Mar. 2026. The stock has 1 warning sign investors should review. Among 203 Medical Diagnostics & Research companies, Invitro International ranks better than 83.25% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Invitro International's Net Income for the three months ended in Mar. 2026 was $0.02 Mil. Invitro International's Revenue for the three months ended in Mar. 2026 was $0.21 Mil. Therefore, Invitro International's net margin for the quarter that ended in Mar. 2026 was 8.70%.

The historical rank and industry rank for Invitro International's Net Margin % or its related term are showing as below:

IVRO' s Net Margin % Range Over the Past 10 Years
Min: -364.29   Med: -172.73   Max: 13.88
Current: 12.2

IVRO's Net Margin % is ranked better than
83.25% of 203 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.69 vs IVRO: 12.20

Invitro International  (OTCPK:IVRO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Invitro International Net Margin % Related Terms

Invitro International Net Margin % Historical Data

* Premium members only.

The historical data trend for Invitro International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International Net Margin % Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96 Sep24 Sep25
Net Margin %
Get a 7-Day Free Trial Premium Member Only -258.82 -254.55 -172.73 13.19 13.88

Invitro International Quarterly Data
Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.63 19.66 12.75 6.01 8.70

IVRO vs IDTA, PRPH, NSTM: Net Margin % Comparison

For the Diagnostics & Research subindustry, Invitro International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invitro International Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Invitro International's Net Margin % falls into.


Invitro International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Invitro International's Net Margin for the fiscal year that ended in Sep. 2025 is calculated as

Net Margin=Net Income (A: Sep. 2025 )/Revenue (A: Sep. 2025 )
=0.122/0.879
=13.88 %

Invitro International's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0.018/0.207
=8.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 8.70% mean?
Invitro International (IVRO) has a Net Margin % of 8.70% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Invitro International and its competitors. According to the industry distribution chart, Invitro International ranks #34 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 16.7%.
Is Invitro International's Net Margin % too high?
Invitro International's current Net Margin % is 8.70%. Based on the distribution chart, Invitro International ranks #34 out of 203 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Invitro International's Net Margin % compare to IDTA and PRPH?
According to the Medical Diagnostics & Research industry distribution chart, Invitro International ranks #34 out of 203 companies for Net Margin %. This places Invitro International in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Invitro International and its competitors. Invitro International's current Net Margin % is 8.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invitro International stock overvalued right now?
Based on GuruFocus' analysis, Invitro International (IVRO) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.05, compared to a current price of $0.07 — trading 35.8% above its estimated fair value. The current Net Margin % is 8.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Invitro International (IVRO), the current Net Margin % is 8.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Invitro International Business Description

Address 330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.